Pcn21 - Comparative Efficacy of Nivolumab±ipilimumab Versus Standard of Care (Soc) for Third-Line (3l) Patients With Recurrent Small Cell Lung Cancer (Sclc) Using Population-Adjusted Indirect Comparison

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.103
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Third-Line Nivolumab Monotherapy in Recurrent Small Cell Lung Cancer: CheckMate 032

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

P1.04-29 Second or Third Line Nivolumab Versus First Line Nivolumab in Patients With Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2020English

P2.12-16 Significant Tumor Regression and Toxicity With Nivolumab Plus Ipilimumab in Small Cell Lung Cancer Patients Following Radiation

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Brain Metastases in Patients With Breast Cancer Versus Non–small Cell Lung Cancer: Comparison of an Unscreened Versus a Screened Population

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Efficacy of Nivolumab in Pre-Treated Non-Small-Cell Lung Cancer Patients Harbouring KRAS Mutations

British Journal of Cancer
Cancer ResearchOncology
2018English

Treatment Paradigms for Patients With Metastatic Non-Small-Cell Lung Cancer: First-, Second-, and Third-Line

Current Oncology
Oncology
2012English

Ipilimumab Combined With Nivolumab: A Standard of Care for the Treatment of Advanced Melanoma?

Clinical Cancer Research
Cancer ResearchOncology
2016English

Lambert-Eaton Myasthenic Syndrome Secondary to Nivolumab and Ipilimumab in a Patient With Small-Cell Lung Cancer

Case Reports in Neurological Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy